- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Pancrelipase.
Displaying page 1 of 1.
EudraCT Number: 2015-001219-11 | Sponsor Protocol Number: PNCRLPCYS3001 | Start Date*: 2015-03-31 | |||||||||||
Sponsor Name:Johnson & Johnson Pharmaceutical Research and Development, L.L.C. | |||||||||||||
Full Title: A randomized double-blind (withdrawal) phase 3 study to evaluate the efficacy and tolerability of pancrelipase MT capsules compared with placebo in the treatment of subjects with cystic fibrosis-d... | |||||||||||||
Medical condition: Cystic fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001438-34 | Sponsor Protocol Number: 20-101 | Start Date*: 2005-05-23 |
Sponsor Name:McNeil Consumer and Specialty Pharmaceuticals | ||
Full Title: A Phase II, Randomized, Investigator-Blinded, Parallel-Group, Pilot Study Evaluating the Safety, Palatability and Efficacy of Four Doses of Pancrelipase Microtablets in the Treatment of Infants and... | ||
Medical condition: Cystic Fibrosis-Related Pancreatic Insufficiency and Fat Malabsorption | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-004004-12 | Sponsor Protocol Number: S245.3.124 | Start Date*: 2008-02-28 | ||||||||||||||||
Sponsor Name:Solvay Pharmaceuticals GmbH | ||||||||||||||||||
Full Title: A STUDY TO INVESTIGATE THE EFFECT OF PANCRELIPASE DELAYED RELEASE CAPSULES ON MALDIGESTION IN PATIENTS WITH EXOCRINE PANCREATIC INSUFFICIENCY DUE TO CHRONIC PANCREATITIS AND PANCREATECTOMY | ||||||||||||||||||
Medical condition: Pancreatic enzyme replacement therapy is the cornerstone of nutritional management of pancreatic exocrine insufficiency (PEI) due to e.g. cystic fibrosis, chronic pancreatitis, partial or complete ... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: BG (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-000342-12 | Sponsor Protocol Number: VIO16EPI07-01 | Start Date*: 2008-03-07 | |||||||||||
Sponsor Name:Axcan Pharma Inc. | |||||||||||||
Full Title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL, PLACEBO-CONTROLLED, PHASE III STUDY TO ASSESS THE SAFETY AND EFFICACY OF VIOKASEĀ® 16 FOR THE CORRECTION OF STEATORRHEA IN PATIENTS WITH EXOCRINE P... | |||||||||||||
Medical condition: Correction of steatorrhea (malabsorption of dietary fats) in patients with exocrine pancreatic insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
